Kang Muslim
A comprehensive new study published in JAMA Pediatrics has found no empirical evidence connecting newborn male circumcision to an increased risk of developing autism spectrum disorder (ASD). Led by researchers at the Johns Hopkins Bloomberg School of Public Health, the investigation evaluated a diverse cohort of nearly 2,800 American boys to address lingering public anxieties. Furthermore, the researchers determined that the administration of acetaminophen—frequently cited in public speculation as a contributing factor—was exceedingly rare among the infants studied, effectively ruling out the pain reliever as a biological link between the surgical procedure and subsequent neurodevelopmental diagnoses.
The findings arrive amid a broader national conversation regarding the shifting landscape of autism diagnoses, early-life medical interventions, and public health transparency. By leveraging a large, multi-site U.S. database, the research team sought to untangle complex variables that have muddied prior observational studies, offering definitive reassurance to pediatricians, parents, and public health officials alike.
Background Context and the Rise of Autism Diagnoses
Autism spectrum disorder is a complex neurodevelopmental condition characterized by persistent differences in social interaction and communication, alongside restricted interests, repetitive body movements, and atypical responses to sensory input. Clinical diagnoses rely heavily on behavioral evaluations and developmental milestones tracked by pediatric specialists.
Over the past two decades, the recorded prevalence of autism has increased dramatically across the United States. According to periodic surveillance summaries from the Centers for Disease Control and Prevention (CDC), approximately one in 150 eight-year-old children was identified with autism in the year 2000. By contrast, CDC estimates published for the year 2022 indicated that approximately one in 31 children met the diagnostic criteria.
Epidemiologists and public health experts attribute this steep incline to a combination of factors. While true environmental or genetic shifts cannot be completely ruled out, a substantial portion of the increase is widely believed to stem from heightened public awareness, broader screening criteria, earlier identification, and expanded diagnostic substitution by healthcare providers. Regardless of the underlying drivers, this upward trend has intensified scientific scrutiny on early-life exposures, particularly those unique to male infants, given that autism is diagnosed significantly more often in boys than in girls.
Chronology of Public Debate and Previous Studies
The question of whether neonatal medical circumcision could be linked to autism is not entirely new, but it gained renewed urgency and mainstream attention following recent high-profile commentary.
The public discourse was significantly amplified in October 2025 during a Cabinet meeting, where Health and Human Services Secretary Robert F. Kennedy Jr. asserted that two prior studies indicated circumcised boys experienced double the rate of autism. He further suggested that acetaminophen, commonly administered for procedural pain relief, was the underlying mechanism.
Media coverage of these remarks rapidly resurfaced two historical observational studies:
- The 2013 Ecological Analysis: A broad cross-country and U.S. state-level comparison that correlated national circumcision rates with autism prevalence.
- The 2015 Danish Health Registry Study: A retrospective analysis of Danish medical records that reported a 46 percent higher risk of autism diagnoses among circumcised boys compared to uncircumcised peers.
However, epidemiologists have long cautioned that these older studies suffered from profound methodological limitations and potential confounding biases. For instance, in nations like Denmark where neonatal circumcision is rare and typically performed for specific cultural or religious reasons, families who choose the procedure may differ systematically from the general population in unmeasured ways—such as healthcare-seeking behaviors, socioeconomic status, or access to diagnostic services—which can artificially skew statistical outcomes.
Recognizing the need for a robust evaluation free from these specific regional biases, the Johns Hopkins research team utilized contemporary data from a diverse American cohort where hospital-based circumcision has historically been a widespread, routine practice across broad demographic strata.
Methodology and Supporting Data of the New Study
Spearheaded by Dr. Monica McGrath, a research professor in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health and director of the Environmental Influences on Child Health Outcomes (ECHO) Data Analysis Center, the new investigation analyzed data from the ECHO project, a nationwide initiative tracking pediatric health and development.
The study population comprised 2,771 singleton male children drawn from 14 distinct research sites across the United States. To eliminate statistical skewing from shared family environments, the researchers randomly selected only one child per family if multiple siblings were enrolled in the broader project.
The investigative protocol involved cross-referencing electronic medical records to verify whether each boy underwent a medical circumcision in a clinical facility within 28 days of birth. Researchers then tracked subsequent autism diagnoses, which were confirmed either through formal clinical assessments or via parental reports of professional medical diagnoses. The average age of autism identification across the cohort was slightly under four years old.
In addition to formal diagnoses, the team evaluated subtler behavioral traits using two validated parent-completed standardized questionnaires:
- The Social Responsiveness Scale (SRS): Completed for 1,886 children to measure the severity of social impairments associated with autism.
- The Child Behavior Checklist (CBCL): Completed for 1,880 children to screen for broader emotional and behavioral problems, including autism-aligned behavioral subsets.
These tools allowed researchers to identify subclinical or milder behavioral traits in children who had not received a formal autism diagnosis.
Detailed Statistical Findings
Out of the 2,771 boys evaluated in the cohort, 1,840 infants (66 percent) were circumcised prior to hospital discharge, while 931 infants (34 percent) remained uncircumcised. Overall, 192 children in the entire sample—representing roughly 7 percent—received a formal autism diagnosis.
Initial unadjusted figures revealed that 6 percent of circumcised boys had an autism diagnosis, compared to 9 percent of uncircumcised boys, suggesting a slightly lower unadjusted diagnosis rate among those who underwent the procedure. However, the two groups exhibited baseline demographic and clinical differences: uncircumcised boys were disproportionately of Hispanic ethnicity, more frequently born in the Western United States or Puerto Rico, and exhibited a higher incidence of premature birth or neonatal intensive care unit (NICU) admission.
Once the research team adjusted for confounding variables—including maternal education, geographic region, family history of autism, and parental age—the statistical gap in formal diagnoses vanished entirely.
Similarly, analyses of the parent-reported behavioral questionnaires revealed no association between neonatal circumcision and elevated autism-related scores. Subgroup analyses focusing on premature infants, NICU admissions, and specific geographic regions corroborated these findings, with isolated variations attributed to normal statistical fluctuation across multiple comparisons.
Investigating the Acetaminophen Hypothesis
A central pillar of the public speculation linking circumcision to autism has been the use of acetaminophen to manage post-procedural pain. To test this hypothesis directly, the research team examined available hospital pain management records for the cohort.
Among the subset of circumcised infants with detailed pain management documentation, only 4 percent received acetaminophen during the procedure, and approximately 7 percent received the medication within 30 days of birth. Instead, clinicians overwhelmingly relied on non-pharmacological and targeted local interventions:
- Nerve Blocks: Administered to 72 percent of infants to effectively numb the surgical area.
- Oral Sucrose Solutions: Given to 59 percent of infants to leverage natural calming mechanisms.
- Combination Therapy: Many infants received multiple concurrent supportive measures.
Because inpatient administration of acetaminophen was exceptionally rare, the investigators concluded that a biological pathway connecting circumcision, the administration of the pain reliever, and the subsequent development of autism is highly improbable.
Official Responses and Expert Perspectives
The publication of the study has drawn widespread commentary from pediatric and epidemiological communities, providing clarity to anxious parents navigating conflicting public claims.
“We knew we had the data to help investigate this question,” Dr. McGrath stated in a Johns Hopkins news release. Emphasizing the practical outcome of the research, she added, “Parents have been concerned about this potential circumcision-autism connection, but hopefully these findings may help allay their fears.”
Medical professionals have echoed these sentiments, noting that large-scale, methodologically sound studies are essential for countering unverified assertions circulated in public discourse. Pediatric associations have consistently highlighted the importance of evidence-based evaluations when reviewing the safety of routine clinical procedures.
Broader Impact, Implications, and Study Limitations
The implications of the JAMA Pediatrics study extend well beyond the immediate debate surrounding neonatal circumcision. By systematically dismantling a hypothesized environmental trigger for autism, the research allows the scientific community to refocus its resources on validated genetic and environmental factors driving neurodevelopmental conditions.
Nevertheless, the study’s authors transparently acknowledged several methodological limitations:
- Health Insurance Status: Data regarding participants’ specific health insurance coverage was limited. Because insurance status can influence both hospital-based healthcare choices and long-term access to specialized developmental diagnostics, unmeasured insurance-related factors could theoretically exert subtle residual influences.
- Scope of Procedure: The investigation specifically evaluated medical circumcisions performed in hospital settings within the first 28 days of life. The findings cannot be generalized to ritual circumcisions, procedures performed later in childhood, or those conducted outside clinical environments.
- Home Medication Tracking: Hospital records captured inpatient acetaminophen administration but could not account for any over-the-counter doses administered independently by parents at home following discharge.
- Diagnostic Screening Tools: While parent-reported behavioral questionnaires are validated and robust screening instruments, they do not replace comprehensive, in-person clinical diagnostic evaluations. Furthermore, while the ECHO cohort is large and geographically diverse, it does not constitute a perfectly randomized representation of every American newborn.
Despite these caveats, the study represents the most rigorous and comprehensive evaluation of the circumcision-autism hypothesis to date. Concluding the report, Dr. McGrath emphasized the ongoing commitment of her team: “We observed no association between circumcision and autism in boys, but it remains important to evaluate the safety of common medical procedures.”
As research moves forward, investigators within the Johns Hopkins Department of Epidemiology and the ECHO network continue to explore other complex, evidence-backed avenues to better understand the multifaceted origins of autism spectrum disorder.
